16-84174729-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_178452.6(DNAAF1):c.1698+7G>T variant causes a splice region, intron change. The variant allele was found at a frequency of 0.335 in 1,613,740 control chromosomes in the GnomAD database, including 94,086 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.28 ( 7003 hom., cov: 33)
Exomes 𝑓: 0.34 ( 87083 hom. )
Consequence
DNAAF1
NM_178452.6 splice_region, intron
NM_178452.6 splice_region, intron
Scores
2
Splicing: ADA: 0.001239
2
Clinical Significance
Conservation
PhyloP100: 3.90
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 16-84174729-G-T is Benign according to our data. Variant chr16-84174729-G-T is described in ClinVar as [Benign]. Clinvar id is 163084.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-84174729-G-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.378 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.1698+7G>T | splice_region_variant, intron_variant | ENST00000378553.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.1698+7G>T | splice_region_variant, intron_variant | 1 | NM_178452.6 | P1 | |||
DNAAF1 | ENST00000563093.5 | c.*260G>T | 3_prime_UTR_variant, NMD_transcript_variant | 11/11 | 2 | ||||
DNAAF1 | ENST00000563818.5 | n.1375+7G>T | splice_region_variant, intron_variant, non_coding_transcript_variant | 2 | |||||
DNAAF1 | ENST00000570298.5 | n.4151+1G>T | splice_donor_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.281 AC: 42642AN: 151964Hom.: 6990 Cov.: 33
GnomAD3 genomes
AF:
AC:
42642
AN:
151964
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.337 AC: 84709AN: 251360Hom.: 15353 AF XY: 0.334 AC XY: 45442AN XY: 135854
GnomAD3 exomes
AF:
AC:
84709
AN:
251360
Hom.:
AF XY:
AC XY:
45442
AN XY:
135854
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.341 AC: 498515AN: 1461658Hom.: 87083 Cov.: 40 AF XY: 0.338 AC XY: 245825AN XY: 727132
GnomAD4 exome
AF:
AC:
498515
AN:
1461658
Hom.:
Cov.:
40
AF XY:
AC XY:
245825
AN XY:
727132
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.281 AC: 42661AN: 152082Hom.: 7003 Cov.: 33 AF XY: 0.285 AC XY: 21181AN XY: 74338
GnomAD4 genome
AF:
AC:
42661
AN:
152082
Hom.:
Cov.:
33
AF XY:
AC XY:
21181
AN XY:
74338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
951
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | 1698+7G>T in intron 10 of DNAAF1: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence. It has been identified in 34.2% (2945/8600) of European American chromoso mes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs .washington.edu/EVS; dbSNP rs3826151). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Primary ciliary dyskinesia 13 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at